MicroPulse Transscleral Laser Therapy Demonstrates Similar Efficacy with a Superior and More Favorable Safety Profile Compared to Continuous-Wave Transscleral Cyclophotocoagulation
Table 1
Demographical data.
All
G-Probe CPC
MicroPulse-TLT
value
Eyes
197
150
47
1.000
OD 98 (49.7%)
OD 75 (50.0%)
OD 23 (48.9%)
OS 99 (50.3%)
OS 75 (50.0%)
OS 24 (51.1%)
Mean age (years)
72.1 ± 15.1 years
73.1 ± 15.5
68.9 ± 13.3
0.072
Gender
90 males (45.7%), 107 females (54.3%)
68 males (45.3%), 82 females (54.7%)
22 males (46.8%), 25 females (53.2%)
0.868
Spherical equivalent
−1.74 ± 4.79
−1.5 ± 4.6
−2.7 ± 5.3
0.320
Baseline BCVA (logMAR)
1.8 ± 2.4
2.0 ± 2.5
1.4 ± 2.2
0.137
Baseline IOP (mmHg)
26.5 ± 11.6
28.0 ± 12.3
21.7 ± 7.2
<0.001
Baseline AGD
3.0 ± 1.4
3.0 ± 1.4
2.9 ± 1.4
0.501
Baseline VF MD (dB)
15.4 ± 9.1
18.3 ± 18.2
8.1 ± 6.4
0.003
Diagnosis
Primary open-angle glaucoma
69 (35.2%)
48 (32.0%)
21 (45.7%)
0.460
Pseudoexfoliative glaucoma
66 (33.7%)
55 (36.7%)
11 (23.9%)
Pigment dispersion glaucoma
5 (2.6%)
3 (2.0%)
2 (4.3%)
Angle-closure glaucoma
13 (6.6%)
9 (6.0%)
4 (8.7%)
Aphakic glaucoma
10 (5.1%)
8 (5.3%)
2 (4.3%)
Ocular hypertension
2 (1.0%)
2 (1.3%)
0 (0%)
Other glaucomas
31 (15.8%)
25 (16.7%)
6 (13%)
OD = right eye, OS = left eye, BCVA = best-corrected visual acuity, logMAR = logarithm of the minimum angle of resolution, IOP = intraocular pressure, mmHg = millimeters of mercury, VF MD = visual field mean defect, dB = decibel.
